Forensic Analysis · Industrials / Manufacturing / Defense · as of Jun 27, 2026
BRUNSWICK CORP (BC)
A forensic read on BRUNSWICK CORP built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
B · Sound & dependable
Forensic grade
Safe
Financial health
3.3
Altman Z-score
Clean
Earnings quality
3
Forensic signals
-8.1%
ROE
$5.7B
Market cap
2.16%
Dividend yield
BRUNSWICK CORP earns a B (Sound & dependable) forensic quality grade, and its Altman Z-score is 3.3, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by receivables vs revenue.
What the filings flag
36d DSOReceivables vs revenue.Days sales outstanding moved from 30 to 36 days FY2024→FY2025 (receivables +22% vs revenue +2%). Receivables are outrunning sales — a flag for aggressive revenue recognition or slipping collections.
-1%Return on invested capital.Return on invested capital is -1% and slipping from 17% — well below its ~9% cost of capital, so reinvested dollars may be destroying value, not building it.
$386MGoodwill impairments.Took $386M of goodwill writedowns across 2 year(s) (FY2024 ($80M), FY2025 ($306M)). Writedowns mean past acquisitions underperformed what was paid for them — worth weighing on capital-allocation skill.
Key fundamentals
Net Margin-2.6%
Debt / Equity1.29x
Free Cash Flow$396.3M
Latest Revenue$5.36B
Return on Equity-8.4%
Revenue Growth YoY+2.4%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on BRUNSWICK CORP:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about BC's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown